{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:28:04Z","timestamp":1793147284770,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI\/12\/RC\/2273_P2"],"award-info":[{"award-number":["SFI\/12\/RC\/2273_P2"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbi.2021.10.020","type":"journal-article","created":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T09:43:10Z","timestamp":1636278190000},"page":"317-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["The immune-kynurenine pathway in social anxiety disorder"],"prefix":"10.1016","volume":"99","author":[{"given":"Mary I.","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitriona","family":"Long-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard M.","family":"Moloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Morkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhain M.","family":"O'Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Cryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Dinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2021.10.020_b0005","unstructured":"APA, A. P. A. (2013) Diagnostic and statistical manual for mental disorders, 5th edition(DSM-V). Arlington, VA: American Psychiatric Publishing."},{"issue":"5","key":"10.1016\/j.bbi.2021.10.020_b0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/15622975.2016.1181783","article-title":"Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics","volume":"17","author":"Bandelow","year":"2016","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.bbi.2021.10.020_b0015","doi-asserted-by":"crossref","unstructured":"Bandelow, B., Charimo Torrente, A., Wedekind, D., Broocks, A., Hajak, G. and R\u00fcther, E. (2004) 'Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder', Eur Arch Psychiatry Clin Neurosci, 254(6), pp. 397-405.","DOI":"10.1007\/s00406-004-0521-2"},{"issue":"3","key":"10.1016\/j.bbi.2021.10.020_b0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.bbi.2021.10.020_b0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1600-0447.108.s417.6.x","article-title":"The lifelong course of social anxiety disorder: a clinical perspective","volume":"417","author":"Keller","year":"2003","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"10","key":"10.1016\/j.bbi.2021.10.020_b0030","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1176\/appi.ajp.157.10.1606","article-title":"Disability and quality of life in social phobia: epidemiologic findings","volume":"157","author":"Stein","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2021.10.020_b0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00127-003-0720-6","article-title":"Considering comorbidity in socialphobia","volume":"38","author":"Chartier","year":"2003","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"8","key":"10.1016\/j.bbi.2021.10.020_b0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archpsyc.64.8.903","article-title":"Incidence of Social Anxiety Disorder and the Consistent Risk for Secondary Depression in the First Three Decades of Life","volume":"64","author":"Beesdo","year":"2007","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0045","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/schbul\/sbp148","article-title":"How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association","volume":"37","author":"Achim","year":"2011","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbi.2021.10.020_b0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.12688\/f1000research.10094.1","article-title":"Understanding the role of serotonin in psychiatric diseases","volume":"6","author":"Marazziti","year":"2017","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0055","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0060","doi-asserted-by":"crossref","first-page":"17024","DOI":"10.1038\/nrdp.2017.24","article-title":"Anxiety disorders","volume":"3","author":"Craske","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0070","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.bbi.2021.10.020_b0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.bbi.2021.10.020_b0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2009.06.003","article-title":"Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels","volume":"57","author":"Mok","year":"2009","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.bbi.2021.10.020_b0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01262727","article-title":"Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice","volume":"42","author":"Lapin","year":"1978","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbi.2021.10.020_b0100","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies","author":"Marx","year":"2020","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.10.020_b0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881108089583","article-title":"Kynurenine pathway in psychosis: evidence of increased tryptophan degradation","volume":"23","author":"Barry","year":"2008","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.bbi.2021.10.020_b0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2018.02.011","article-title":"Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy","volume":"100","author":"Allen","year":"2018","journal-title":"J Psychiatr Res"},{"issue":"5\u20136","key":"10.1016\/j.bbi.2021.10.020_b0115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","article-title":"Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression","volume":"61","author":"Myint","year":"2003","journal-title":"Med Hypotheses"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2021.10.020_b0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0125","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr Bull"},{"issue":"7","key":"10.1016\/j.bbi.2021.10.020_b0130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bdi.12009","article-title":"Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder","volume":"14","author":"Olsson","year":"2012","journal-title":"Bipolar Disorders"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41398-019-0378-9","article-title":"Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls","volume":"9","author":"Sellgren","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"Pt B","key":"10.1016\/j.bbi.2021.10.020_b0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.01.034","article-title":"Kynurenine pathway metabolites and suicidality","volume":"112","author":"Bryleva","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2021.10.020_b0145","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59 Suppl 20","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbi.2021.10.020_b0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Mod Probl Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S0033291798007879","article-title":"Psychometric properties of the Liebowitz Social Anxiety Scale","volume":"29","author":"Heimberg","year":"1999","journal-title":"Psychol Med"},{"issue":"6","key":"10.1016\/j.bbi.2021.10.020_b0160","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S0033291701004056","article-title":"The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats","volume":"31","author":"Fresco","year":"2001","journal-title":"Psychol Med"},{"issue":"6","key":"10.1016\/j.bbi.2021.10.020_b0165","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0005-7967(01)00060-2","article-title":"The liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis","volume":"40","author":"Baker","year":"2002","journal-title":"Behav Res Ther"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jclp.10124","article-title":"A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale","volume":"59","author":"Oakman","year":"2003","journal-title":"J Clin Psychol"},{"issue":"8","key":"10.1016\/j.bbi.2021.10.020_b0175","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00213-014-3767-z","article-title":"Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome","volume":"232","author":"Kennedy","year":"2015","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbi.2021.10.020_b0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-3223(94)91189-4","article-title":"Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression","volume":"36","author":"Orlikov","year":"1994","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0185","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0006-3223(91)90225-B","article-title":"Caffeine-induced anxiety and increase of Kynurenine concentration in plasma of healthy subjects: A pilot study","volume":"29","author":"Orlikov","year":"1991","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbi.2021.10.020_b0190","doi-asserted-by":"crossref","unstructured":"Keane, J. M., Khashan, A. S., McCarthy, F. P., Kenny, L. C., Collins, J. M., O'Donovan, S., Brown, J., Cryan, J. F., Dinan, T. G., Clarke, G. and O'Mahony, S. M. (2021) 'Identifying a biological signature of prenatal maternal stress', JCI insight, 6(2). PubMed. DOI: 10.1172\/jci.insight.143007 (Accessed 2021\/01\/\/).","DOI":"10.1172\/jci.insight.143007"},{"key":"10.1016\/j.bbi.2021.10.020_b0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpsychires.2019.03.027","article-title":"Elevated peripheral kynurenine\/tryptophan ratio predicts poor short-term auditory memory in panic disorder patients","volume":"113","author":"Quagliato","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bbi.2021.10.020_b0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2015.12.020","article-title":"Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase","volume":"54","author":"Fuertig","year":"2016","journal-title":"Brain, Behavior, and Immunity"},{"issue":"7","key":"10.1016\/j.bbi.2021.10.020_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011825","article-title":"Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans","volume":"5","author":"Kiank","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bbi.2021.10.020_b0210","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00213-020-05507-x","article-title":"Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex","volume":"237","author":"Klausing","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"Pt B","key":"10.1016\/j.bbi.2021.10.020_b0215","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2015.12.004","article-title":"Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders","volume":"112","author":"O'Farrell","year":"2017","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.bbi.2021.10.020_b0220","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000455228","article-title":"Restraint Stress during Pregnancy Rapidly Raises Kynurenic Acid Levels in Mouse Placenta and Fetal Brain","volume":"38","author":"Notarangelo","year":"2016","journal-title":"Developmental Neuroscience"},{"issue":"7","key":"10.1016\/j.bbi.2021.10.020_b0225","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jamapsychiatry.2014.243","article-title":"Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance","volume":"71","author":"Chiappelli","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","article-title":"Skeletal Muscle PGC-1\u03b11 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression","volume":"159","author":"Agudelo","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0235","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-019-10712-0","article-title":"Skeletal muscle PGC-1\u03b11 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance","volume":"10","author":"Agudelo","year":"2019","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.bbi.2021.10.020_b0240","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.pnpbp.2009.02.002","article-title":"\u03b2-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling","volume":"33","author":"Luchowska","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/10253890.2016.1265939","article-title":"Autonomic markers associated with generalized social phobia symptoms: heart rate variability and salivary alpha-amylase","volume":"20","author":"Garc\u00eda-Rubio","year":"2017","journal-title":"Stress"},{"issue":"10","key":"10.1016\/j.bbi.2021.10.020_b0250","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.psyneuen.2008.07.004","article-title":"Elevated alpha-amylase but not cortisol in generalized social anxiety disorder","volume":"33","author":"van Veen","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00726-008-0031-z","article-title":"Presence of kynurenic acid in food and honeybee products","volume":"36","author":"Turski","year":"2009","journal-title":"Amino Acids"},{"issue":"Pt 3","key":"10.1016\/j.bbi.2021.10.020_b0260","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/bj3600617","article-title":"Kynurenine aminotransferase and glutamine transaminase K of Escherichia coli: identity with aspartate aminotransferase","volume":"360","author":"Han","year":"2001","journal-title":"The Biochemical journal"},{"issue":"2","key":"10.1016\/j.bbi.2021.10.020_b0265","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00726-007-0631-z","article-title":"Micromolar concentration of kynurenic acid in rat small intestine","volume":"35","author":"Kuc","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbi.2021.10.020_b0270","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0021-9258(19)83769-9","article-title":"The metabolism of quinaldic acid, kynurenic acid, and xanthurenic acid in the rabbit","volume":"237","author":"Kaihara","year":"1962","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbi.2021.10.020_b0275","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0021-9258(18)64026-8","article-title":"Studies on the metabolism of kynurenic acid. I. The formation of L-glutamic acid, D- and L-alanine, and acetic acid from kynurenic acid by Pseudomonas extracts","volume":"236","author":"Hayaishi","year":"1961","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbi.2021.10.020_b0280","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0006-3002(63)91023-0","article-title":"Microbial oxidation of kynurenic, xanthurenic and picolinic acids","volume":"78","author":"Dagley","year":"1963","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0285","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-clinpsy-050718-095432","article-title":"Man and the Microbiome: A New Theory of Everything?","volume":"15","author":"Butler","year":"2019","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.bbi.2021.10.020_b0290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coph.2019.08.004","article-title":"Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis","volume":"48","author":"Gheorghe","year":"2019","journal-title":"Curr Opin Pharmacol"},{"issue":"Pt B","key":"10.1016\/j.bbi.2021.10.020_b0295","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","article-title":"Kynurenine pathway metabolism and the microbiota-gut-brain axis","volume":"112","author":"Kennedy","year":"2017","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.bbi.2021.10.020_b0300","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.4049\/jimmunol.0803104","article-title":"Blockade of Indoleamine 2,3-Dioxygenase Protects Mice against Lipopolysaccharide-Induced Endotoxin Shock","volume":"182","author":"Jung","year":"2009","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.bbi.2021.10.020_b0305","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions","volume":"8","author":"Wirthgen","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.bbi.2021.10.020_b0310","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cmet.2015.07.004","article-title":"Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production","volume":"22","author":"Metghalchi","year":"2015","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.bbi.2021.10.020_b0315","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbi.2011.05.002","article-title":"Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder","volume":"25","author":"Sublette","year":"2011","journal-title":"Brain Behav Immun"},{"issue":"2-3","key":"10.1016\/j.bbi.2021.10.020_b0320","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psychres.2015.03.031","article-title":"The role of the kynurenine pathway in suicidality in adolescent major depressive disorder","volume":"227","author":"Bradley","year":"2015","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.bbi.2021.10.020_b0325","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2021.10.020_b0330","doi-asserted-by":"crossref","unstructured":"Brundin, L., Sellgren, C. M., Lim, C. K., Grit, J., P\u00e5lsson, E., Land\u00e9n, M., Samuelsson, M., Lundgren, K., Brundin, P., Fuchs, D., Postolache, T. T., Traskman-Bendz, L., Guillemin, G. J. and Erhardt, S. (2016) 'An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation', Translational Psychiatry, 6(8), pp. e865-e865.","DOI":"10.1038\/tp.2016.133"},{"issue":"2","key":"10.1016\/j.bbi.2021.10.020_b0335","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/anxi.3070010203","article-title":"Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia","volume":"1","author":"Rapaport","year":"1994","journal-title":"Anxiety"},{"issue":"6","key":"10.1016\/j.bbi.2021.10.020_b0340","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0006-3223(97)00263-1","article-title":"Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers","volume":"43","author":"Rapaport","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.10.020_b0345","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.psychres.2009.05.008","article-title":"Lipopolysaccharide-induced cytokine production in obsessive-compulsive disorder and generalized social anxiety disorder","volume":"178","author":"Fluitman","year":"2010","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0350","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.27","article-title":"Anxiety disorders and inflammation in a large adult cohort","volume":"3","author":"Vogelzangs","year":"2013","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.bbi.2021.10.020_b0355","doi-asserted-by":"crossref","unstructured":"Bellavance, M.-A. and Rivest, S. (2014) 'The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain', Frontiers in immunology, 5, pp. 136-136.","DOI":"10.3389\/fimmu.2014.00136"},{"issue":"6","key":"10.1016\/j.bbi.2021.10.020_b0360","first-page":"826","article-title":"The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation","volume":"28","author":"Maes","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"issue":"9","key":"10.1016\/j.bbi.2021.10.020_b0365","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: The Master Regulator of Immunity to Infection","volume":"180","author":"Couper","year":"2008","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/j.bbi.2021.10.020_b0370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychires.2008.02.004","article-title":"IL-10 modulates depressive-like behavior","volume":"43","author":"Mesquita","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bbi.2021.10.020_b0375","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbi.2017.01.021","article-title":"Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study","volume":"62","author":"Hou","year":"2017","journal-title":"Brain, Behavior, and Immunity"},{"issue":"1","key":"10.1016\/j.bbi.2021.10.020_b0380","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2010.07.018","article-title":"Enhanced Th17 phenotype in individuals with generalized anxiety disorder","volume":"229","author":"Vieira","year":"2010","journal-title":"Journal of Neuroimmunology"},{"issue":"5","key":"10.1016\/j.bbi.2021.10.020_b0385","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/da.20564","article-title":"Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder","volume":"26","author":"Hoge","year":"2009","journal-title":"Depress Anxiety"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0390","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1995-7645(12)60048-0","article-title":"Study on serum cytokine levels in posttraumatic stress disorder patients","volume":"5","author":"Guo","year":"2012","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"issue":"6","key":"10.1016\/j.bbi.2021.10.020_b0395","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0400","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2021.10.020_b0405","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S1461145702003164","article-title":"Effects of antidepressants on the production of cytokines","volume":"5","author":"Kenis","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.bbi.2021.10.020_b0410","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","article-title":"Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma\/interleukin-10 production ratio","volume":"21","author":"Kubera","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.bbi.2021.10.020_b0415","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00702-011-0668-8","article-title":"New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid\/3-hydroxykynurenine ratio","volume":"119","author":"Kocki","year":"2012","journal-title":"J Neural Transm (Vienna)"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121005961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121005961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:17:58Z","timestamp":1760170678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121005961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":83,"alternative-id":["S0889159121005961"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.10.020","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immune-kynurenine pathway in social anxiety disorder","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}